文献速递细菌感染、耐药与抗菌药物

报告的青霉素过敏是否足以放弃β-内酰胺类抗生素的多维抗菌益处?

Is a Reported Penicillin Allergy Sufficient Grounds to Forgo the Multidimensional Antimicrobial Benefits of β-Lactam Antibiotics?
PubMed 文献 · Clin Infect Dis · 2019-01-01

大多数报告青霉素过敏的患者经检测或激发试验证实并不过敏,青霉素过敏检测可显著降低年度医疗支出。β-内酰胺类在体内具有超出标准药敏试验所反映的多维抗菌效应,包括增强固有免疫系统杀菌。近期临床与药物经济学分析显示,报告青霉素过敏者接受非β-内酰胺类抗生素时结局更差,在金黄色葡萄球菌菌血症治疗中尤为相关。本文综述β-内酰胺治疗的巨大优势,并强烈主张通过详细过敏史和青霉素过敏检测破除虚假青霉素过敏应成为抗菌药物管理实践的重要组成部分。

要点

  • 大多数报告青霉素过敏的患者经检测或激发试验证实并不过敏。
  • β-内酰胺类在体内具有增强固有免疫系统杀菌等多维抗菌效应。
  • 报告青霉素过敏者接受非β-内酰胺类抗生素时结局更差。

核心结论

  • 破除虚假青霉素过敏应成为抗菌药物管理实践的重要组成部分。

研究设计与样本

  • 本文为综述,检索范围原文未报告。

主要发现

  • 大多数报告青霉素过敏的患者经检测或激发试验证实并不过敏。
  • 青霉素过敏检测已被证明可显著降低年度医疗支出。
  • β-内酰胺类在体内具有超出标准药敏试验所反映的多维抗菌效应,包括增强固有免疫系统杀菌。
  • 近期临床与药物经济学分析显示,报告青霉素过敏者接受非β-内酰胺类抗生素时结局较无青霉素过敏者更差。
  • 这在金黄色葡萄球菌菌血症治疗中尤为相关。

临床怎么用

  • 作者主张通过详细过敏史和青霉素过敏检测破除虚假青霉素过敏应成为抗菌药物管理实践的重要组成部分。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The majority of patients with reported penicillin allergy are not allergic when tested or challenged. Penicillin allergy testing has been shown to significantly reduce annual healthcare expenditures. Data have emerged showing β-lactams have multidimensional antibacterial effects in vivo, far beyond what is appreciated in standard bacteriological susceptibility testing media. These include enhancing bacterial killing by the innate immune system. Supporting the clinical relevance of these secondary underappreciated effects are recent clinical and pharmacoeconomic analyses that show worse outcomes in patients with reported penicillin allergies who receive non-β-lactam antibiotics when compared to their non-penicillin-allergic counterparts. This is particularly relevant in the treatment of Staphylococcus aureus bacteremia. This article reviews the tremendous advantages offered by β-lactam therapy and makes a strong case that the debunking of false penicillin allergies through a detailed allergy history and penicillin allergy testing should be a vital component of antimicrobial stewardship practices.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Sakoulas G, Geriak M, Nizet V, et al. Is a Reported Penicillin Allergy Sufficient Grounds to Forgo the Multidimensional Antimicrobial Benefits of β-Lactam Antibiotics? Clin Infect Dis. 2019. PMID: 29986019. doi:10.1093/cid/ciy557

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。